Treating Depression Among Low-Income Patients With Cancer
ADAPt-C
Effectiveness Study of a Stepped Care Depression Algorithm for Patients With Cancer
2 other identifiers
interventional
472
1 country
1
Brief Summary
The ADAPt-C collaborative depression care model is designed to: improve depression symptom reduction in the intervention group over the modestly enhanced usual care group of low-income, predominantly Hispanic, patients with cancer who are receiving care in an urban public sector care system; and to improve quality of life outcomes among intervention patients over enhanced usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
November 27, 2007
CompletedFirst Posted
Study publicly available on registry
November 29, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedResults Posted
Study results publicly available
July 24, 2017
CompletedJuly 24, 2017
April 1, 2017
4.6 years
November 27, 2007
March 10, 2017
April 21, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Reduced Depression Symptoms
Number of participants with 50% PHQ-9 score reduction since baseline
12 months
Secondary Outcomes (1)
Physical Composite Summary Score (PCS) Derived From the 12-item Short Form (SF-12) Health Survey
12 months
Study Arms (2)
Enhanced Usual Care
NO INTERVENTIONEUC patients receive medical center standard oncology care and supportive services routinely provided to all patients with cancer. In addition, EUC patients are given a patient focused and a family focused educational pamphlet on depression and cancer and a listing of financial and community resources (in Spanish for Spanish-speaking patients). With patient consent, as described in the informed written consent, the treating oncologist is informed via medical chart note if EUC patients screen positive for major depression. Treating oncology attending physicians, fellows and residents are invited to attend a didactic session led by the study psychiatrist on treating depression in cancer patients.
ADAPt-C intervention
EXPERIMENTALIntervention patients receive: first-line choice of antidepressant medication management,psychotherapy or both; depression education, and maintenance/relapse prevention counseling based on a stepped care depression treatment algorithm, treatment follow-up and feedback to the oncologist, and systems navigation; a psychiatric consultant who prescribes antidepressant medication for individual patients; and a didactic for oncologists on depression management. Cultural adaptations include: patient choice of first line treatment and degree of family participation in their depression care; PST tailored for literacy and patients with cancer; bilingual, bicultural CDCS; Spanish educational materials.
Interventions
Experimental Arm patients receive: first-line choice of antidepressant medication management,psychotherapy or both; depression education, and maintenance/relapse prevention counseling based on a stepped care depression treatment algorithm, treatment follow-up and feedback to the oncologist, and systems navigation; a psychiatric consultant who prescribes antidepressant medication for individual patients; and a didactic for oncologists on depression management. Cultural adaptations include: patient choice of first line treatment and degree of family participation in their depression care; PST tailored for literacy and patients with cancer; bilingual, bicultural CDCS; Spanish educational materials.
Eligibility Criteria
You may qualify if:
- \- 90 days post cancer diagnosis receiving acute cancer treatment or active follow-up
You may not qualify if:
- \- patients with advanced cancer or another medical condition that limited life expectancy to less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Los Angeles County+University of Southern California Medical Center
Los Angeles, California, 90033, United States
Related Publications (1)
Ell K, Quon B, Quinn DI, Dwight-Johnson M, Wells A, Lee PJ, Xie B. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry. 2007 May-Jun;29(3):223-31. doi: 10.1016/j.genhosppsych.2007.01.005.
PMID: 17484939BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Kathleen Ell, DSW, Principle Investigator
- Organization
- USC Suzanne Dworak-Peck School of Social Work
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen R Ell, DSW
University of Southern California, School of Social Work
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 27, 2007
First Posted
November 29, 2007
Study Start
June 1, 2004
Primary Completion
January 1, 2009
Study Completion
July 1, 2010
Last Updated
July 24, 2017
Results First Posted
July 24, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will share
National Cancer Institute, "Project ADAPT-C" selected for Research-Tested Interventions NCI Program 2014, http://rtips.cancer.gov/rtips/programDetails.do?programId=3551008. https://researchtoreality.cancer.gov/featured-r2r-partners/kathleen-ell-dsw 1\. ADAPt-C randomized clinical trial selected by the Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS Consortia) led by the Netherlands